[Biological properties and clinical applications of interferon gamma (IFN-gamma)] [0.03%]
[干扰素γ的生物学特性和临床应用]
T Robak
T Robak
Interferon-gamma (IFN-gamma) is produced by activated T cells and probably by NK cells. Its production can be induced by mitogens, antigens and other molecules. IFN-gamma interacts with cells by binding to specific membrane receptors. IFN-g...
[Bone marrow fibrosis in neoplastic diseases of the hematopoietic system] [0.03%]
[骨髓纤维化在造血系统肿瘤中的表现]
M Komarnicki,M Rasińska
M Komarnicki
Bone marrow fibrosis appears with diverse extension in most neoplastic diseases of blood. It may cause difficulties in establishing a firm diagnosis. In some cases bone marrow fibrosis has a prognostic value.
Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388 [0.03%]
2-氯脱氧腺苷与环磷酰胺对小鼠白血病L1210和P388的协同作用
J Góra-Tybor,T Robak
J Góra-Tybor
The influence of 2-chlorodeoxyadenosine (2-CDA) administered alone and in combination with cyclophosphamide (CY) or methotrexate (MTX) on the survival time of mice bearing L1210 or P388 leukemia was investigated. 2-CDA given alone significa...
[Complete remission in a patient with hairy cell leukemia after treatment with 2-chlorodeoxyadenosine] [0.03%]
2氯脱氧腺苷治疗血管免疫母细胞性T细胞淋巴瘤1例完全缓解
M Komarnicki,M Kaźmierczak
M Komarnicki
Case Reports
Acta haematologica Polonica. 1993;24(1):77-81. DOI: 1993
[Use of recombinant hematopoietic growth factors in autologous bone marrow transplantation and peripheral blood stem cell transplantation] [0.03%]
造血生长因子在自体骨髓移植和外周血干细胞移植中应用价值的探讨
J Hołowiecki
J Hołowiecki
The number of bone marrow transplantation's in autologous settings is recently rising by 20% each year reflecting a great demand. Simultaneously new technics of autologous transplantation are being developed such as APBSCT, transplantation ...
J Hansz
J Hansz
Presently the following cytokines are applied in allogeneic bone marrow transplantation: GM-CSF (granulocyte/macrophage colony stimulating factor), G-CSF (granulocyte colony stimulating factor), interleukin 3 (IL-3) and interferon-alfa (IFN...
The role of hematopoietic growth factors in the treatment of cancer and leukemias [0.03%]
细胞生长因子在癌症和白血病治疗中的作用
T Büchner
T Büchner
The introduction of hematopoietic growth factors during the last 5 years has changed the scenery of anti-tumor treatment. Growth factors following high dose chemotherapy or bone marrow transplantation have become established as part of many...
K Kuliczkowski
K Kuliczkowski
W Wiktor-Jedrzejczak,P Szwech
W Wiktor-Jedrzejczak
CSF-1 structure and its receptor are known at present and, moreover, this factor is available in recombinant form for further studies. The research on biological role CSF-1 is greatly facilitated by the availability of op/op mice, totally d...
M Podolak-Dawidziak
M Podolak-Dawidziak